Archives

  • January-April
    Vol. 5 No. 1 (2024)

    Transjugular intrahepatic portosystemic intrahepatic shunt (TIPS) comprises joining one of the suprahepatic veins and a portal branch, in order to shunt a percentage of blood flow and therefore decompress the portal venous system.

  • September-October
    Vol. 4 No. 3 (2023)

    Two patients with Budd-Chiari syndrome before and after treatment with TIPS.  
  • May-August
    Vol. 4 No. 2 (2023)

    Globally, 300 million people are infected with the hepatitis B virus (HBV). With recent advances in molecular analysis, new HBV biomarkers have been identified.

  • January-April
    Vol. 4 No. 1 (2023)

    Disruption of the symbiosis that exists between the human body and its microbiome can result in dysbiosis, which can be associated with gastrointestinal and hepatobiliary diseases.

  • July-December
    Vol. 3 No. 2 (2022)

    Despite considering COVID-19 as a primarily respiratory disease, the SARS-CoV-2 virus is also an important cause of hepatobiliary diseases.

  • January-June
    Vol. 3 No. 1 (2022)

    Liver diseases are a major cause of morbidity and mortality worldwide.
  • July-December
    Vol. 2 No. 2 (2021)

    Pathophysiology of non-alcoholic fatty liver disease (NAFLD).

  • January-June
    Vol. 2 No. 1 (2021)

    Magnetic resonance imaging after Fontan procedure.
  • July-December
    Vol. 1 No. 2 (2020)

    Graphic representation of the replicative cycle of the hepatitis delta virus (HDV).
  • January-June
    Vol. 1 No. 1 (2020)

    Illustration of the hepatitis B virus (HBV)